MTOR and breast cancer: The expression of PI3K, AKT, and mTOR was reduced in miR-383-5p-transfected BC cells, indicating that miR-383-5p acts as a tumor inhibitor by suppressing the PI3K/AKT/mTOR axis (Azarbarzin et al., 2021).